CT-Based Radiomics Nomogram for Prediction of Progression-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma
Chang Yan,De-Song Shen,Xiao-Bo Chen,Dan-Ke SU,Zhong-Guo Liang,Kai-Hua Chen,Ling Li,Xia Liang,Hai Liao,Xiao-Dong Zhu
DOI: https://doi.org/10.2147/CMAR.S325373
2021-09-03
Cancer Management and Research
Abstract:Chang Yan, 1 De-Song Shen, 1 Xiao-Bo Chen, 2 Dan-Ke SU, 3 Zhong-Guo Liang, 1 Kai-Hua Chen, 1 Ling Li, 1 Xia Liang, 1 Hai Liao, 3 Xiao-Dong Zhu 1, 4 1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China; 2 School of First Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China; 3 Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China; 4 Affiliated Wuming Hospital of Guangxi Medical University, Nanning, Guangxi, 530100, People's Republic of China Correspondence: Xiao-Dong Zhu Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, 71 Hedi Road, Nanning City, Guangxi, 530021, People's Republic of China Tel +86 771 533 1466 Email Hai Liao Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China Tel +86 771 533 4950 Email Purpose: We aimed to construct of a nomogram to predict progression-free survival (PFS) in locoregionally advanced nasopharyngeal carcinoma (LA-NPC) with risk stratification using computed tomography (CT) radiomics features and clinical factors. Patients and Methods: A total of 311 patients diagnosed with LA-NPC (stage III–IVa) at our hospital between 2010 and 2014 were included. The region of interest (ROI) of the primary nasopharyngeal mass was manually outlined. Independent sample t -test and LASSO-logistic regression were used for selecting the most predictive radiomics features of PFS, and to generate a radiomics signature. A nomogram was built with clinical factors and radiomics features, and the risk stratification model was tested accordingly. Results: In total, 20 radiomics features most associated with prognosis were selected. The radiomics nomogram, which integrated the radiomics signature and significant clinical factors, showed excellent performance in predicting PFS, with C-index of 0.873 (95% CI: 0.803∼ 0.943), which was better than that of the clinical nomogram (C-index, 0.729, 95% CI: 0.620∼ 0.838) as well as of the TNM staging system (C-index, 0.689, 95% CI: 0.592– 0.787) in validation cohort. The calibration curves and the decision curve analysis (DCA) plot obtained suggested satisfying accuracy and clinical utility of the model. The risk stratification tool was able to predict differences in prognosis of patients in different risk categories ( p < 0.001). Conclusion: CT-based radiomics features, an in particular, radiomics nomograms, have the potential to become an accurate and reliable tool for assisting with prognosis prediction of LA-NPC. Keywords: computed tomography, locoregionally advanced nasopharyngeal carcinoma, radiomics, nomogram Nasopharyngeal carcinoma (NPC) is one of the most prevalent head and neck malignant tumors in China, with a characteristic geographical distribution: the highest incidence is found in southern China. 1 Due to its intrinsic biological characteristics and anatomical features, early disease symptoms and signs are not obvious, and many patients already present locally advanced stage when they are first diagnosed. 2 Given that intensity-modulated radiotherapy (IMRT) is widely used in recent years, the local control of NPC has improved significantly, but patients with advanced disease still tend to experience local recurrence and distant metastasis. 3 Combination of chemotherapy with radiotherapy can enhance the efficacy of radiotherapy alone in eliminating micrometastases, and improve the prognosis of locoregionally advanced nasopharyngeal carcinoma LA-NPC. 4 Nevertheless, such combination strategy can also increase the radiotherapy and chemotherapy related side effects and add to the economic burden of health care. The TNM staging system (AJCC 8th edition) provide important information to help clinicians improve NPC clinical care and diagnosis. However, patients with similar TNM staging often have different prognosis and experience different course of the disease. The reason for this may be related to intrinsic biological variability and tumor heterogeneity in different patients. Therefore, how to personalize treatment regimens to minimize the toxic side effects of aggressive therapies while obtaining a promising prognosis remains a clinical challenge. A reliable prognostic model can assist clinicians with their predictions of a patient's prognosis and help them make more informed therapeutic decisions. Radiomics has become a popular research topic in -Abstract Truncated-
oncology